Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Post

Showing results (481-490 of 512) with videos related to

Pageof 52
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implicationsM A Kling, D L Gardner, A E Calogero, et al.
Journal of Affective Disorders|June 3, 1998
Olanzapine in treatment-resistant bipolar disorderS L McElroy, M Frye, K Denicoff, et al.
The New England Journal of Medicine|May 22, 1986
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implicationsP W Gold, D L Loriaux, A Roy, et al.
Biological Psychiatry|July 1, 1999
Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depressionM A Frye, R T Dunn, K A Gary, et al.
Neuropsychiatry, Neuropsychology, and Behavioral Neurology|April 26, 2000
Cognitive effects of 1- and 20-hertz repetitive transcranial magnetic stimulation in depression: preliminary reportJ T Little, T A Kimbrell, E M Wassermann, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 1991
Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implicationsM A Kling, A Roy, A R Doran, et al.
Journal of Affective Disorders|June 11, 1999
Lamotrigine for the treatment of bipolar disorder: a clinical case seriesT Suppes, E S Brown, S L McElroy, et al.
International Clinical Psychopharmacology|April 27, 2004
Use of quetiapine in bipolar disorder: a case series with prospective evaluationT Suppes, S L McElroy, P E Keck, et al.
Acta Psychiatrica Scandinavica|October 22, 2013
Increased parental history of bipolar disorder in the United States: association with early age of onsetR M Post, G S Leverich, R Kupka, et al.
Neuroendocrinology|January 1, 1993
Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretionM A Kling, D R Rubinow, A R Doran, et al.
Pageof 52

Showing results (481-490 of 512) with videos related to

Sort By:
Pageof 52
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implicationsM A Kling, D L Gardner, A E Calogero, et al.
Journal of Affective Disorders|June 3, 1998
Olanzapine in treatment-resistant bipolar disorderS L McElroy, M Frye, K Denicoff, et al.
The New England Journal of Medicine|May 22, 1986
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implicationsP W Gold, D L Loriaux, A Roy, et al.
Biological Psychiatry|July 1, 1999
Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depressionM A Frye, R T Dunn, K A Gary, et al.
Neuropsychiatry, Neuropsychology, and Behavioral Neurology|April 26, 2000
Cognitive effects of 1- and 20-hertz repetitive transcranial magnetic stimulation in depression: preliminary reportJ T Little, T A Kimbrell, E M Wassermann, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 1991
Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implicationsM A Kling, A Roy, A R Doran, et al.
Journal of Affective Disorders|June 11, 1999
Lamotrigine for the treatment of bipolar disorder: a clinical case seriesT Suppes, E S Brown, S L McElroy, et al.
International Clinical Psychopharmacology|April 27, 2004
Use of quetiapine in bipolar disorder: a case series with prospective evaluationT Suppes, S L McElroy, P E Keck, et al.
Acta Psychiatrica Scandinavica|October 22, 2013
Increased parental history of bipolar disorder in the United States: association with early age of onsetR M Post, G S Leverich, R Kupka, et al.
Neuroendocrinology|January 1, 1993
Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretionM A Kling, D R Rubinow, A R Doran, et al.
Pageof 52